Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteregimmune.com
CategoryBioTech
Employees
Founded3/2006

Offices

Tokyo, JPN
1-7-8 Kaigan
Tokyo Industry Trade Center 607 (6th Floor)
Tokyo, 105-0022, JPN

Funding

Tags

REGiMMUNE Corporation

REGiMMUNE Corporation is a biotechnology company focused on the discovery, development, and potential commercialization of immune-regulatory therapeutics to treat life-threatening diseases and debilitating disorders, including allergies, autoimmune and inflammatory disease. REGiMMUNE applies its reVax (reverse vaccination) technology and product development and clinical experience to generate, support and potentially commercialize a broad range of products for itself and its partners.

Recent Milestones

Videos

Screenshots

REGiMMUNE Corporation screenshot
Above: REGiMMUNE Corporation
Uploaded: 12/19/09

Sources

  1. Completed Seed Round Financing (regimmune.com) [edit]
  2. REGiMMUNE Announces Series A Financing (regimmune.com) [edit]
  3. REGiMMUNE Closes First Tranche of Series B Financing (regimmune.com) [edit]
  4. Regimmune Closes $9.2M Series D Financing (finsmes.com) [edit]
Edit This Page
Last Edited 2/16/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy